三维超声在宫内节育器放置后8周内检出位置异常的发生率及危险因素
该回顾性研究纳入763例宫内节育器放置病例,均在放置时行二维超声、8周内行三维经阴道超声复查。三维超声检出节育器位置异常总体发生率为16.6%(95%CI 14.0-19.3),其中8.8%(95%CI 6.8-10.8)需取出。病态肥胖、既往子宫窗口或破裂、铜质节育器及随访时有出血或疼痛症状是位置异常的独立危险因素。
要点
- 三维超声复查可检出16.6%的节育器位置异常,其中8.8%需取出。
- 病态肥胖、既往子宫窗口或破裂、铜质节育器为独立危险因素。
- 随访有出血或疼痛症状者位置异常风险升高,应优先三维超声评估。
核心结论
- 宫内节育器放置后8周内三维超声检出位置异常的发生率为16.6%,其中8.8%需取出。
- 病态肥胖、既往子宫窗口或破裂、铜质节育器放置及随访时有出血或疼痛症状是位置异常的独立危险因素。
- 研究结果支持在看似成功的节育器放置后常规进行三维超声随访。
研究设计与样本
- 回顾性研究,纳入2015年1月1日至2020年12月31日在一家大型妇产科诊所放置宫内节育器的女性,共763例放置病例。
- 所有患者放置时行二维超声,并在8周内常规行三维经阴道超声复查。
- 比较位置正常与位置异常女性的基线特征和潜在危险因素,采用logistic回归计算比值比以识别独立相关因素。
关键影像表现/征象
- 三维经阴道超声用于检出宫内节育器位置异常,位置异常总体发生率为16.6%(95%CI 14.0-19.3)。
- 位置异常病例中需取出的比例为8.8%(95%CI 6.8-10.8)。
诊断标准与关键数值
- 位置异常组病态肥胖比例13.4% vs 3.8%,调整比值比2.46(95%CI 1.10-5.50)。
- 位置异常组既往子宫窗口或破裂比例9.0% vs 2.2%,调整比值比2.78(95%CI 1.06-7.30)。
- 位置异常组铜质宫内节育器比例64.2% vs 47.4%,调整比值比1.99(95%CI 1.31-3.03)。
- 位置异常组随访时有出血或疼痛等症状比例35.8% vs 20.1%,调整比值比2.58(95%CI 1.67-3.98)。
- 产次、哺乳、放置困难及子宫大小和位置与位置异常无显著关联。
临床应用与阅片要点
- 对病态肥胖、既往子宫窗口或破裂、使用铜质节育器及随访有出血或疼痛症状的患者,应重视三维超声随访评估节育器位置。
- 即使放置时二维超声显示位置正常,仍建议在8周内行三维经阴道超声复查以排除位置异常。
局限性
- 回顾性研究设计。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To estimate the incidence of intrauterine device (IUD) malpositioning detected on three-dimensional (3D) transvaginal ultrasound within 8 weeks of placement and identify risk factors for malpositioning.
METHODS: Retrospective study of women who had an IUD placed at a large obstetrics and gynecology practice from January 1, 2015, to December 31, 2020. All patients underwent two-dimensional ultrasound at the time of insertion and routine three-dimensional ultrasound within 8 weeks. Baseline characteristics and potential risk factors were compared between women with correctly positioned and malpositioned IUDs. Odds ratios were calculated by logistic regression to identify risk factors independently associated with malpositioning.
RESULTS: A total of 763 IUD placements were included, and 127 malpositioned IUDs were identified representing an overall rate of malpositioning of 16.6% (95% confidence interval [CI] 14.0-19.3) with 8.8% (95% CI 6.8-10.8) requiring removal. Patients with malpositioned IUD had higher rates of morbid obesity (13.4% versus 3.8%, adjusted odds ratio [aOR] 2.46, 95% CI 1.10-5.50), prior uterine window or rupture (9.0% versus 2.2%, aOR 2.78, 95% CI 1.06-7.30), copper IUD placement (64.2% versus 47.4%, aOR 1.99, 95% CI 1.31-3.03), and symptoms such as bleeding or pain at follow-up (35.8% versus 20.1%, aOR 2.58, 95% CI 1.67-3.98). Parity, breastfeeding, difficult insertion, and uterine size and positioning were not significant.
CONCLUSIONS: The incidence of malpositioned IUD within 8 weeks of placement on 3D ultrasound is 16.6%, with 8.8% requiring removal. Significant risk factors for malpositioning include morbid obesity, prior uterine window or rupture, and copper IUD placement. These findings support the importance of routine follow-up 3D ultrasound after seemingly successful IUD placement.
引用
- Connolly CT, Fox NS. Incidence and Risk Factors for a Malpositioned Intrauterine Device Detected on Three-Dimensional Ultrasound Within Eight Weeks of Placement. J Ultrasound Med. 2021. PMID: 34580900. doi:10.1002/jum.15836
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。